Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...
02/01/2025 14:07 {Hot Stocks}4 listed firms see price swing at 2:06pm 02/01/2025 09:50 {Hot Stocks}2 listed firms see price swing at 9:49am 30/12/2024 13:50 {Hot Stocks}4 listed firms see price swing ...
WHAT’S in store for Philippine taekwondo for the year 2025 and beyond—its directions, goals and expectations—will be tackled ...
Armed with $115 million and a clinical-stage asset, another player is emerging in the increasingly crowded T cell engager ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
What’s in store for Philippine taekwondo for the year 2025 and beyond – its directions, goals and expectations – will be ...
WHAT'S in store for Philippine taekwondo for the year 2025 and beyond – its directions, goals and expectations – will be ...
What’s in store for Philippine taekwondo for the year 2025 and beyond – its directions, goals and expectations – will be ...
The Hong Kong stock market has finished lower in four straight sessions, retreating more than 520 points or 2.8 percent along the ...
Hot Stocks}2 listed firms see price swing at 9:48am 10/01/2025 09:48 {Hot Stocks}BUD APAC(01876) quoted at HK$6.92, down 0.4% 10/01/2025 09:41 {Hot Stocks}SMIC(00981) quoted at HK$33.2, up 5.6% ...
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: The Biopharmaceutical Contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback